Efficacy, safety and quality of life (QoL) with Lanreotide Autogel (LAN) 120 mg every 14 days in progressive pancreatic or midgut neuroendocrine tumors (NETs): CLARINET FORTE study results - Pavel, Marianne Ellen; Cwikla, J. B.; Lombard-Bohas, C.; Borbath,; Shah, T.; Pape, U. F.; Thanh, Truong X. M.; Houchard, A.; Ruszniewski, P. (JOURNAL OF NEUROENDOCRINOLOGY, 2021)
CRIS-Team WoS Importer:2021-03-12